The future of clinical trials in secondary prevention after acute coronary syndromes

被引:23
作者
Bueno, Hector [1 ]
Armstrong, Paul W. [2 ]
Buxton, Martin J. [3 ]
Danchin, Nicolas [4 ,5 ]
Lubsen, Jacobus [6 ]
Roland, Edmond [7 ]
Verheugt, Freek W. [8 ]
Zalewski, Andrew [9 ]
Jackson, Neville [10 ]
Komajda, Michel [11 ]
Steg, Ph Gabriel [12 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid 28007, Spain
[2] Univ Alberta, Edmonton, AB, Canada
[3] Brunel Univ, Uxbridge UB8 3PH, Middx, England
[4] Hop Europeen Georges Pompidou, Paris, France
[5] Univ Paris 05, Paris, France
[6] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
[7] AFSSAPS, Paris, France
[8] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands
[9] Novartis, E Hanover, NJ USA
[10] Pfizer, New London, CT USA
[11] Hop La Pitie Salpetriere, Paris, France
[12] Univ Paris 07, INSERM, Ctr Hosp Bichat Claude Bernard, U698, Paris, France
关键词
MYOCARDIAL-INFARCTION; RANDOMIZED-TRIALS;
D O I
10.1093/eurheartj/ehq388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1583 / 1589
页数:7
相关论文
共 20 条
[1]   Clinical trials bureaucracy: unintended consequences of well-intentioned policy [J].
Califf, Robert M. .
CLINICAL TRIALS, 2006, 3 (06) :496-502
[2]   Clinical Research Sites-The Underappreciated Component of the Clinical Research System [J].
Califf, Robert M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (18) :2025-2027
[3]   How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey [J].
Cleland, JGF .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :243-247
[4]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[5]  
European Commission, 2002, CPMPEWP90899 EUR MED, P10
[6]  
European Medicines Agency, 2007, GUID EV MED PROD CAR, P6
[7]   Composite outcomes in randomized trials - Greater precision but with greater uncertainty? [J].
Freemantle, N ;
Calvert, M ;
Wood, J ;
Eastaugh, J ;
Griffin, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19) :2554-2559
[8]   The role of cardiac registries in evidence-based medicine [J].
Gitt, Anselm K. ;
Bueno, Hector ;
Danchin, Nicolas ;
Fox, Kevin ;
Hochadel, Matthias ;
Kearney, Peter ;
Maggioni, Aldo P. ;
Opolski, Grzegorz ;
Seabra-Gomes, Ricardo ;
Weidinger, Franz .
EUROPEAN HEART JOURNAL, 2010, 31 (05) :525-U9
[9]   Ethical and Scientific Implications of the Globalization of Clinical Research [J].
Glickman, Seth W. ;
McHutchison, John G. ;
Peterson, Eric D. ;
Cairns, Charles B. ;
Harrington, Robert A. ;
Califf, Robert M. ;
Schulman, Kevin A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (08) :816-823
[10]   A single European currency for EQ-5D health statesResults from a six-country study [J].
Wolfgang Greiner ;
Tom Weijnen ;
Martin Nieuwenhuizen ;
Siem Oppe ;
Xavier Badia ;
Jan Busschbach ;
Martin Buxton ;
Paul Dolan ;
Paul Kind ;
Paul Krabbe ;
Arto Ohinmaa ;
David Parkin ;
Montserat Roset ;
Harri Sintonen ;
Aki Tsuchiya ;
Frank de Charro .
The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (3) :222-231